根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 美东时间 2019-02-12 盘后 披露财报,预期EPS -0.02 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-01-04 AccNo: 0001437749-19-000263 Size: 18 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2019-01-04 AccNo: 0001437749-19-000263 Size: 18 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2018-12-28 AccNo: 0001437749-18-022745 Size: 16 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$IsoRay(ISR)$ EFFECT - Notice of Effectiveness Filed: 2018-12-14 AccNo: 9999999995-18-003131 Size: 1 KB 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2018-12-17 AccNo: 0001437749-18-022119 Size: 135 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrang...
$IsoRay(ISR)$ 8-K - Current report Filed: 2018-12-20 AccNo: 0001437749-18-022402 Size: 40 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-12-20 AccNo: 0001437749-18-022402 Size: 40 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-12-17 AccNo: 0001437749-18-022119 Size: 135 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory ...
$IsoRay, Inc.(ISR)$ EFFECT - Notice of Effectiveness Filed: 2018-12-14 AccNo: 9999999995-18-003131 Size: 1 KB 网页链接